NASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis $1.39 -0.06 (-4.14%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DocGo Stock (NASDAQ:DCGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DocGo alerts:Sign Up Key Stats Today's Range$1.38▼$1.4450-Day Range$1.39▼$2.8652-Week Range$1.35▼$5.68Volume868,917 shsAverage Volume792,399 shsMarket Capitalization$141.76 millionP/E Ratio4.96Dividend YieldN/APrice Target$3.56Consensus RatingModerate Buy Company OverviewDocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Read More… DocGo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreDCGO MarketRank™: DocGo scored higher than 75% of companies evaluated by MarketBeat, and ranked 245th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingDocGo has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageDocGo has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about DocGo's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth-68.00% Earnings GrowthEarnings for DocGo are expected to decrease by -68.00% in the coming year, from $0.25 to $0.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is 4.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.12.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is 4.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.83.Price to Earnings Growth RatioDocGo has a PEG Ratio of 14.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDocGo has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DocGo's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.58% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 6.3.Change versus previous monthShort interest in DocGo has recently decreased by 1.06%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.58% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 6.3.Change versus previous monthShort interest in DocGo has recently decreased by 1.06%, indicating that investor sentiment is improving. News and Social Media2.6 / 5News Sentiment0.75 News SentimentDocGo has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 19 news articles for DocGo this week, compared to 3 articles on an average week.Search Interest1 people have searched for DCGO on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added DocGo to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $58,200.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of DocGo is held by insiders.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address DCGO Stock News HeadlinesDocGo Inc. (NASDAQ:DCGO) Director Buys $21,450.00 in StockMay 16, 2025 | insidertrades.comStephen Sugrue Acquires 10,000 Shares of DocGo Inc. (NASDAQ:DCGO) StockMay 15, 2025 | insidertrades.comWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."May 21, 2025 | Brownstone Research (Ad)DocGo Wins "Compliance Management Innovation Award" in 2025 MedTech Breakthrough Awards ProgramMay 19 at 9:12 AM | finance.yahoo.comDocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards ProgramMay 19 at 7:35 AM | businesswire.comDocGo Inc. (NASDAQ:DCGO) Receives $3.56 Average PT from AnalystsMay 19 at 2:05 AM | americanbankingnews.comNorthland Capmk Analysts Reduce Earnings Estimates for DocGoMay 15, 2025 | americanbankingnews.comCanaccord Genuity Group Reaffirms Hold Rating for DocGo (NASDAQ:DCGO)May 14, 2025 | americanbankingnews.comSee More Headlines DCGO Stock Analysis - Frequently Asked Questions How have DCGO shares performed this year? DocGo's stock was trading at $4.24 at the start of the year. Since then, DCGO shares have decreased by 67.2% and is now trading at $1.39. View the best growth stocks for 2025 here. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.08. The business earned $96.03 million during the quarter, compared to analysts' expectations of $104.25 million. DocGo had a net margin of 4.35% and a trailing twelve-month return on equity of 8.90%. Read the conference call transcript. Who are DocGo's major shareholders? DocGo's top institutional investors include WCM Investment Management LLC (3.18%), Punch & Associates Investment Management Inc. (2.16%), Jefferies Financial Group Inc. (1.99%) and P.A.W. Capital Corp (1.96%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, James M Travers, Anthony Capone, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DocGo own? Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings5/08/2025Today5/20/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:DCGO CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees2,920Year FoundedN/APrice Target and Rating Average Stock Price Target$3.56 High Stock Price Target$5.50 Low Stock Price Target$1.45 Potential Upside/Downside+156.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E Ratio4.96 Forward P/E Ratio5.56 P/E Growth14.16Net Income$6.86 million Net Margins4.35% Pretax Margin6.69% Return on Equity8.90% Return on Assets5.72% Debt Debt-to-Equity RatioN/A Current Ratio2.19 Quick Ratio2.19 Sales & Book Value Annual Sales$520.50 million Price / Sales0.27 Cash Flow$0.06 per share Price / Cash Flow23.62 Book Value$2.93 per share Price / Book0.47Miscellaneous Outstanding Shares101,983,000Free Float99,296,000Market Cap$141.76 million OptionableOptionable Beta1.14 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:DCGO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.